Back

Genetic modifiers of triglyceride-mediated mortality in coronary heart disease: a large cohort study of polygenic risk and circulating triglyceride level interaction

29 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Lipid profiling and coronary artery disease (1) Lipids ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Fanyong Xu

Beijing (China)

5 More presentations in this session

Presentation thumbnail
Longitudinal patterns and determinants of lipoprotein(a) variability: a 15-year multi-center study
Doctor D. Chen (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
DysfunctionalH5 HDLl is a carrier of pro-inflammatory sphingolipid cargo: large-scale lipidomic and apolipoprotein profiling
Miss H. Hsu (TW)
Abstract Slides Video
Presentation thumbnail
Genetic-phenotypic discordance reveals divergent cardiovascular risk at extremes of HDL
Doctor E. Shemesh (Hamilton, CA)
Abstract Slides Video
Presentation thumbnail
Qualitative over quantitative lipids: electronegative subfractions h5 and l5 reveal hidden cardiovascular risk independent of standard lipid panels
Doctor W. Hsu (Yunlin, TW)
Abstract Slides Video
Presentation thumbnail
Lipid variability as an independent predictor of major adverse cardiovascular events: a systematic review and meta-analysis
Associate Professor O. Rueda Ochoa (Bucaramanga, CO)
Abstract Slides Video

Access the full session

Session thumbnail
Lipid profiling and coronary artery disease (1)

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between triglyceride with all-cause mortality and cardiovascular outcomes in heart failure patients
26 August 2023
thumbnail
Congress Presentation
Polygenic risk score as a predictor of coronary artery disease severity and plaque features in CCTA
31 August 2026
thumbnail
Congress Presentation
Association of ANGPTL3, ANGPTL4, and DOCK7 polymorphisms with lipid traits and long-term clinical outcomes in patients undergoing PCI
31 August 2026
thumbnail
Congress Presentation
Remnant cholesterol and triglyceride-rich lipoproteins: what human genetics tells us about causality beyond LDL
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources